Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
- PMID: 40203113
- PMCID: PMC11980859
- DOI: 10.1126/sciadv.adq2519
Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma
Abstract
Although an increased risk of the skin cancer melanoma in people with Parkinson's disease (PD) has been shown in multiple studies, the mechanisms involved are poorly understood, but increased expression of the PD-associated protein alpha-synuclein (αSyn) in melanoma cells may be important. Our previous work suggests that αSyn can facilitate DNA double-strand break (DSB) repair, promoting genomic stability. We now show that αSyn is preferentially enriched within the nucleolus in melanoma, where it colocalizes with DNA damage markers and DSBs. Inducing DSBs specifically within nucleolar ribosomal DNA (rDNA) increases αSyn levels near sites of damage. αSyn knockout increases DNA damage within the nucleolus at baseline, after specific rDNA DSB induction, and prolongs the rate of recovery from this induced damage. αSyn is important downstream of ataxia-telangiectasia-mutated signaling to facilitate MDC1-mediated 53BP1 recruitment to DSBs, reducing micronuclei formation and promoting cellular proliferation, migration, and invasion.
Figures
Update of
-
Alpha-synuclein regulates nucleolar DNA double-strand break repair in melanoma.bioRxiv [Preprint]. 2024 Jan 14:2024.01.13.575526. doi: 10.1101/2024.01.13.575526. bioRxiv. 2024. Update in: Sci Adv. 2025 Apr 11;11(15):eadq2519. doi: 10.1126/sciadv.adq2519. PMID: 38260370 Free PMC article. Updated. Preprint.
References
-
- Bajaj A., Driver J. A., Schernhammer E. S., Parkinson’s disease and cancer risk: A systematic review and meta-analysis. Cancer Causes Control 21, 697–707 (2010). - PubMed
-
- Ong E. L., Goldacre R., Goldacre M., Differential risks of cancer types in people with Parkinson’s disease: A national record-linkage study. Eur. J. Cancer 50, 2456–2462 (2014). - PubMed
-
- Skibba J. L., Pinckley J., Gilbert E. F., Johnson R. O., Multiple primary melanoma following administration of levodopa. Arch. Pathol. 93, 556–561 (1972). - PubMed
-
- Olsen J. H., Friis S., Frederiksen K., Malignant melanoma and other types of cancer preceding Parkinson disease. Epidemiology 17, 582–587 (2006). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
